Non-Invasive Ventilation, Sleep Therapy (CPAP) and Sleep Monitoring (Diagnostics)

Description

NHS Supply Chain intends to launch a National Framework Agreement for the provision of Non-Invasive Ventilation (NIV): Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BPAP), High Flow Therapy Devices and Sleep Diagnostic and Monitoring Devices with Associated Consumables and Sleep and Respiratory Managed Services / Purchase Plans • Lot 1: Non-Invasive Ventilation (NIV), Sleep Therapy and Sleep Monitoring devices, systems and associated consumables The NIV (Sleep Therapy and Sleep Monitoring Diagnostics and Associated Consumables Framework Agreement is intended to cover Non-Invasive Ventilation (NIV), Sleep Devices and Sleep Monitoring products and Sleep and Respiratory managed services. It is anticipated in the first year that the spend will be 40,000,000 GBP, however this is approximate and may vary depending on requirements of bodies purchasing under the Framework. The Framework Agreement between NHS Supply Chain and successful suppliers will reserve the right to purchase the same or similar supplies and/or services from suppliers not appointed to the Framework Agreement at its sole discretion. NHS Supply Chain intends to enter arrangements under which it will be entitled to purchase supplies which it will make available for purchase by 1) any NHS Trust; 2) any other NHS entity; 3) any government department, agency or other statutory body and/or 4) any private sector entity active in the UK healthcare sector. Only NHS Supply Chain can order from the Framework Agreement and enter into contracts under it. The framework agreement will run from 18/09/2025 – 17/09/2029 (4 years). Lot Lot 1: Non-Invasive Ventilation (NIV), Sleep Therapy and Sleep Monitoring devices, systems and associated consumables To provide all Non-Invasive Ventilation & Sleep Therapy & Monitoring to the NHS, through devices, associated consumables and services. Additional information: The minimum yearly turnover requirements should not exceed twice the estimated contract value, “except in duly justified cases”. If contracting authority has a justifiable case, then this must be set out in the procurement documents or in the Regulation 84 Report (or both).